To evaluate whether quantitative MRI parameters are sensitive to the effects of the tyrosine kinase inhibitor gefitinib and can discriminate between two different treatment protocols.
MRI methods for evaluating the effects of tyrosine kinase inhibitor administration used to enhance chemotherapy efficiency in a breast tumor xenograft model.
Department of Radiology and Biomedical Imaging, University of California at San Francisco, San Francisco, California 94107, USA. sheye.aliu@radiology.ucsf.edu